Does the media favor WST or CHE?

In the previous week, West Pharmaceutical Services had 18 more articles in the media than Chemed. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 1 mentions for Chemed. West Pharmaceutical Services' average media sentiment score of 0.90 beat Chemed's score of 0.00 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Chemed 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to WST or EHC?

In the previous week, West Pharmaceutical Services had 10 more articles in the media than Encompass Health. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 9 mentions for Encompass Health. Encompass Health's average media sentiment score of 1.33 beat West Pharmaceutical Services' score of 0.90 indicating that Encompass Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Encompass Health 8 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to WST or COO?

In the previous week, West Pharmaceutical Services had 7 more articles in the media than Cooper Companies. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 12 mentions for Cooper Companies. West Pharmaceutical Services' average media sentiment score of 0.90 beat Cooper Companies' score of 0.50 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cooper Companies 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral

Does the media prefer ALGN or WST?

In the previous week, West Pharmaceutical Services had 11 more articles in the media than Align Technology. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 8 mentions for Align Technology. West Pharmaceutical Services' average media sentiment score of 0.90 beat Align Technology's score of 0.42 indicating that West Pharmaceutical Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral West Pharmaceutical Services 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to WST or MMSI?

In the previous week, West Pharmaceutical Services had 13 more articles in the media than Merit Medical Systems. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 6 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.94 beat West Pharmaceutical Services' score of 0.90 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 10 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

West Pharmaceutical Services (WST) Competitors

$314.48 +2.31 (+0.74%)

As of 02:02 PM Eastern

Compare

WST vs. CHE, EHC, COO, ALGN, and MMSI

Should you buy West Pharmaceutical Services stock or one of its competitors? MarketBeat compares West Pharmaceutical Services with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with West Pharmaceutical Services include Chemed (CHE), Encompass Health (EHC), Cooper Companies (COO), Align Technology (ALGN), and Merit Medical Systems (MMSI). These companies are all part of the "medical" sector.

How does West Pharmaceutical Services compare to Chemed?

West Pharmaceutical Services (NYSE:WST) and Chemed (NYSE:CHE) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

West Pharmaceutical Services has a net margin of 16.85% compared to Chemed's net margin of 10.23%. Chemed's return on equity of 27.18% beat West Pharmaceutical Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Chemed	10.23%	27.18%	17.38%

West Pharmaceutical Services has a beta of 1.18, suggesting that its share price is 18% more volatile than the broader market. Comparatively, Chemed has a beta of 0.54, suggesting that its share price is 46% less volatile than the broader market.

West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Chemed pays an annual dividend of $2.40 per share and has a dividend yield of 0.6%. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Chemed pays out 13.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has raised its dividend for 16 consecutive years. Chemed is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

West Pharmaceutical Services currently has a consensus target price of $331.91, indicating a potential upside of 5.54%. Chemed has a consensus target price of $501.50, indicating a potential upside of 18.10%. Given Chemed's higher possible upside, analysts clearly believe Chemed is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93
Chemed	0 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

West Pharmaceutical Services has higher revenue and earnings than Chemed. Chemed is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	7.23	$493.70M	$7.48	42.04
Chemed	$2.54B	2.22	$265.24M	$18.35	23.14

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 95.8% of Chemed shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by insiders. Comparatively, 3.3% of Chemed shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, West Pharmaceutical Services had 18 more articles in the media than Chemed. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 1 mentions for Chemed. West Pharmaceutical Services' average media sentiment score of 0.90 beat Chemed's score of 0.00 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	10 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Chemed	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

West Pharmaceutical Services beats Chemed on 12 of the 20 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Encompass Health?

West Pharmaceutical Services (NYSE:WST) and Encompass Health (NYSE:EHC) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings.

West Pharmaceutical Services has a net margin of 16.85% compared to Encompass Health's net margin of 10.04%. West Pharmaceutical Services' return on equity of 19.03% beat Encompass Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Encompass Health	10.04%	18.28%	8.27%

Encompass Health has higher revenue and earnings than West Pharmaceutical Services. Encompass Health is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	7.23	$493.70M	$7.48	42.04
Encompass Health	$5.94B	1.71	$566.20M	$5.99	17.05

93.9% of West Pharmaceutical Services shares are held by institutional investors. Comparatively, 97.3% of Encompass Health shares are held by institutional investors. 0.6% of West Pharmaceutical Services shares are held by company insiders. Comparatively, 1.8% of Encompass Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

West Pharmaceutical Services has a beta of 1.18, suggesting that its stock price is 18% more volatile than the broader market. Comparatively, Encompass Health has a beta of 0.72, suggesting that its stock price is 28% less volatile than the broader market.

West Pharmaceutical Services pays an annual dividend of $0.88 per share and has a dividend yield of 0.3%. Encompass Health pays an annual dividend of $0.76 per share and has a dividend yield of 0.7%. West Pharmaceutical Services pays out 11.8% of its earnings in the form of a dividend. Encompass Health pays out 12.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Encompass Health has raised its dividend for 2 consecutive years. Encompass Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

West Pharmaceutical Services presently has a consensus price target of $331.91, suggesting a potential upside of 5.54%. Encompass Health has a consensus price target of $142.75, suggesting a potential upside of 39.74%. Given Encompass Health's stronger consensus rating and higher probable upside, analysts clearly believe Encompass Health is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93
Encompass Health	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	2 Strong Buy rating(s)	3.10

In the previous week, West Pharmaceutical Services had 10 more articles in the media than Encompass Health. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 9 mentions for Encompass Health. Encompass Health's average media sentiment score of 1.33 beat West Pharmaceutical Services' score of 0.90 indicating that Encompass Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	10 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Encompass Health	8 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

West Pharmaceutical Services beats Encompass Health on 10 of the 19 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Cooper Companies?

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, dividends, earnings, institutional ownership, risk, profitability, valuation and analyst recommendations.

West Pharmaceutical Services currently has a consensus target price of $331.91, indicating a potential upside of 5.54%. Cooper Companies has a consensus target price of $88.07, indicating a potential upside of 45.87%. Given Cooper Companies' higher possible upside, analysts clearly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93
Cooper Companies	1 Sell rating(s)	7 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.53

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. Cooper Companies is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	7.23	$493.70M	$7.48	42.04
Cooper Companies	$4.09B	2.88	$374.90M	$2.02	29.89

West Pharmaceutical Services has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

In the previous week, West Pharmaceutical Services had 7 more articles in the media than Cooper Companies. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 12 mentions for Cooper Companies. West Pharmaceutical Services' average media sentiment score of 0.90 beat Cooper Companies' score of 0.50 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	10 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cooper Companies	2 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Neutral

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 2.1% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

West Pharmaceutical Services has a net margin of 16.85% compared to Cooper Companies' net margin of 9.67%. West Pharmaceutical Services' return on equity of 19.03% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Cooper Companies	9.67%	10.34%	6.93%

Summary

West Pharmaceutical Services beats Cooper Companies on 14 of the 17 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Align Technology?

Align Technology (NASDAQ:ALGN) and West Pharmaceutical Services (NYSE:WST) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, risk, profitability, institutional ownership and earnings.

West Pharmaceutical Services has lower revenue, but higher earnings than Align Technology. Align Technology is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	2.88	$410.35M	$5.96	27.25
West Pharmaceutical Services	$3.07B	7.23	$493.70M	$7.48	42.04

West Pharmaceutical Services has a net margin of 16.85% compared to Align Technology's net margin of 10.50%. West Pharmaceutical Services' return on equity of 19.03% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	10.50%	15.82%	10.17%
West Pharmaceutical Services	16.85%	19.03%	14.06%

Align Technology currently has a consensus price target of $205.85, indicating a potential upside of 26.76%. West Pharmaceutical Services has a consensus price target of $331.91, indicating a potential upside of 5.54%. Given Align Technology's higher possible upside, research analysts plainly believe Align Technology is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 0.8% of Align Technology shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Align Technology has a beta of 1.67, meaning that its share price is 67% more volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.18, meaning that its share price is 18% more volatile than the broader market.

In the previous week, West Pharmaceutical Services had 11 more articles in the media than Align Technology. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 8 mentions for Align Technology. West Pharmaceutical Services' average media sentiment score of 0.90 beat Align Technology's score of 0.42 indicating that West Pharmaceutical Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
West Pharmaceutical Services	10 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

West Pharmaceutical Services beats Align Technology on 13 of the 17 factors compared between the two stocks.

How does West Pharmaceutical Services compare to Merit Medical Systems?

West Pharmaceutical Services (NYSE:WST) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, earnings and media sentiment.

West Pharmaceutical Services has a beta of 1.18, indicating that its share price is 18% more volatile than the broader market. Comparatively, Merit Medical Systems has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market.

In the previous week, West Pharmaceutical Services had 13 more articles in the media than Merit Medical Systems. MarketBeat recorded 19 mentions for West Pharmaceutical Services and 6 mentions for Merit Medical Systems. Merit Medical Systems' average media sentiment score of 0.94 beat West Pharmaceutical Services' score of 0.90 indicating that Merit Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	10 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Merit Medical Systems	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

West Pharmaceutical Services has a net margin of 16.85% compared to Merit Medical Systems' net margin of 9.03%. West Pharmaceutical Services' return on equity of 19.03% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.85%	19.03%	14.06%
Merit Medical Systems	9.03%	13.54%	7.94%

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 99.7% of Merit Medical Systems shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by company insiders. Comparatively, 0.7% of Merit Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

West Pharmaceutical Services has higher revenue and earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.07B	7.23	$493.70M	$7.48	42.04
Merit Medical Systems	$1.52B	2.38	$128.49M	$2.31	26.23

West Pharmaceutical Services presently has a consensus target price of $331.91, suggesting a potential upside of 5.54%. Merit Medical Systems has a consensus target price of $92.80, suggesting a potential upside of 53.19%. Given Merit Medical Systems' higher probable upside, analysts plainly believe Merit Medical Systems is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.93
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64

Summary

West Pharmaceutical Services beats Merit Medical Systems on 13 of the 17 factors compared between the two stocks.

Get West Pharmaceutical Services News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WST vs. The Competition

Export

Metric	West Pharmaceutical Services	MED/DENTAL Industry	Medical Sector	NYSE Exchange
Market Cap	$22.22B	$14.25B	$6.26B	$23.14B
Dividend Yield	0.28%	1.21%	2.69%	4.09%
P/E Ratio	42.05	17.17	22.42	31.05
Price / Sales	7.23	2.08	548.01	14.78
Price / Cash	32.48	13.42	42.31	24.78
Price / Book	7.13	3.19	9.82	4.68
Net Income	$493.70M	$534.24M	$3.56B	$1.07B
7 Day Performance	0.72%	-1.04%	-1.17%	-0.46%
1 Month Performance	4.64%	5.00%	3.71%	0.43%
1 Year Performance	49.17%	-3.10%	27.28%	25.81%

West Pharmaceutical Services Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WST West Pharmaceutical Services	4.2475 of 5 stars	$314.48 +0.7%	$331.91 +5.5%	+49.3%	$22.22B	$3.07B	42.05	10,800	News Coverage Analyst Upgrade
CHE Chemed	3.5114 of 5 stars	$439.70 +0.1%	$501.50 +14.1%	-26.6%	$5.83B	$2.53B	23.96	15,811	Analyst Upgrade
EHC Encompass Health	4.6078 of 5 stars	$105.04 +0.1%	$145.29 +38.3%	-15.9%	$10.41B	$5.94B	17.54	42,000	Positive News
COO Cooper Companies	4.0847 of 5 stars	$62.55 flat	$90.79 +45.1%	-11.2%	$12.20B	$4.09B	30.97	15,000	Trending News Upcoming Earnings Analyst Forecast
ALGN Align Technology	3.3991 of 5 stars	$163.61 flat	$205.85 +25.8%	-6.6%	$11.72B	$4.03B	27.45	20,290	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:WST) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, COO, ALGN, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

West Pharmaceutical Services (WST) Competitors

WST vs. CHE, EHC, COO, ALGN, and MMSI

How does West Pharmaceutical Services compare to Chemed?

Is WST or CHE more profitable?

Which has more risk and volatility, WST or CHE?

Is WST or CHE a better dividend stock?

Do analysts rate WST or CHE?

Which has preferable earnings & valuation, WST or CHE?

Do insiders & institutionals have more ownership in WST or CHE?

Does the media favor WST or CHE?

Summary

How does West Pharmaceutical Services compare to Encompass Health?

Is WST or EHC more profitable?

Which has stronger valuation & earnings, WST or EHC?

Do institutionals & insiders have more ownership in WST or EHC?

Which has more risk & volatility, WST or EHC?

Is WST or EHC a better dividend stock?

Do analysts prefer WST or EHC?

Does the media refer more to WST or EHC?

Summary

How does West Pharmaceutical Services compare to Cooper Companies?

Do analysts recommend WST or COO?

Which has higher earnings & valuation, WST or COO?

Which has more volatility & risk, WST or COO?

Does the media refer more to WST or COO?

Do institutionals and insiders believe in WST or COO?

Is WST or COO more profitable?

Summary

How does West Pharmaceutical Services compare to Align Technology?

Which has better earnings and valuation, ALGN or WST?

Is ALGN or WST more profitable?

Do analysts rate ALGN or WST?

Do institutionals & insiders hold more shares of ALGN or WST?

Which has more volatility & risk, ALGN or WST?

Does the media prefer ALGN or WST?

Summary

How does West Pharmaceutical Services compare to Merit Medical Systems?

Which has more risk & volatility, WST or MMSI?

Does the media refer more to WST or MMSI?

Is WST or MMSI more profitable?

Do insiders and institutionals hold more shares of WST or MMSI?

Which has better earnings & valuation, WST or MMSI?

Do analysts rate WST or MMSI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

WST vs. The Competition

West Pharmaceutical Services Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools